GlassScriptPhysician profile
Omer M Mirza
NPI 1497044259
$3,949.43
in general payments reported to CMS, 2019-2025
25 companies · $764 in 2025
The $764 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $294 · 2020: $144 · 2021: $586 · 2022: $1,043 · 2023: $774 · 2024: $346 · 2025: $764.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,883.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,883.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $436.66 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boston Scientific Corporation | $400.64 | 2020-2025 | General - Vascular Access, General - Therapies, Watchman Access System |
| Abiomed | $399.01 | 2019-2023 | Impella |
| Astrazeneca Pharmaceuticals LP | $360.43 | 2020-2024 | Lokelma |
| Amgen INC. | $358.62 | 2021-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $342.56 | 2019-2024 | |
| Medtronic, INC. | $206.88 | 2021-2025 | Micra, Onyx Frontier |
| Pfizer INC. | $203.05 | 2022-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $200.85 | 2019-2025 | Lifevest |
| Penumbra, INC. | $149.65 | 2023 | Indigo System |
| Siemens Medical Solutions USA, INC. | $134.13 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $104.33 | 2019-2023 | |
| Cardiovascular Systems INC. | $100.24 | 2019 | |
| Abbott Laboratories | $91.73 | 2022-2025 | Ensite Precision, Cardiomems |
| Janssen Pharmaceuticals, INC | $86.76 | 2020-2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $70.08 | 2022-2023 | Eliquis |
| Imperative Care, INC | $57.88 | 2025 | Symphony Catheter |
| Merck Sharp & Dohme LLC | $48.33 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $44.47 | 2020-2022 | |
| Heartflow, INC. | $37.74 | 2022 | |
| Esperion Therapeutics, INC. | $32.32 | 2022 | |
| Stryker Corporation | $26.73 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Kestra Medical Technology Services, INC. | $24.51 | 2022-2023 | Assure Wcd |
| Novo Nordisk INC | $16.73 | 2023 | Ozempic, Rybelsus |
| Cvrx, INC. | $15.10 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Omer Mirza listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.